Sygnature Discovery Strengthens its Drug Discovery Services and Client Communication with Dotmatics ELN and Data Discovery Platform

Sygnature Discovery Streamlines CRO Operations with Dotmatics

As a global leader in drug discovery, Sygnature Discovery needed a flexible, scalable R&D platform to support its diverse client base and growing research demands. By implementing the Dotmatics ELN and Data Discovery Platform, the organization enhanced collaboration, accelerated lab workflows, and improved data visibility across teams and client engagements.

Key Outcomes:

• Flexible R&D Workflows: Customizable ELN templates and a standardized framework support consistent, tailored experiment documentation.

• Operational Efficiency: Centralized inventory, automated assay analysis, and integrated request management tools streamline lab operations.

• Improved Data Access: Centralized, indexed data with federated search and permission-based controls improves speed and traceability.

• Client Transparency: A dedicated web portal and customizable reports offer real-time visibility into project progress.

With Dotmatics, Sygnature Discovery is delivering faster, more transparent, and more efficient drug discovery services for its clients worldwide.